CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Tamoxifen Therapy for Myotubular Myopathy [Phase 1, Phase 2]
Summary
Phase 1/Phase 2 trial of tamoxifen for X-linked myotubular myopathy has terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: James Dowling | Conditions: X Linked Myotubular Myopathy | Phase 1, Phase 2 | Status: TERMINATED